Congress Asset Management’s Cantel Medical Corporation CMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q4
Sell
-65,632
Closed -$6.04M 384
2018
Q3
$6.04M Buy
65,632
+1,795
+3% +$171K 0.08% 160
2018
Q2
$6.28M Sell
63,837
-5,675
-8% -$635K 0.09% 146
2018
Q1
$7.74M Buy
69,512
+5,849
+9% +$656K 0.11% 112
2017
Q4
$6.55M Sell
63,663
-3,934
-6% -$392K 0.1% 131
2017
Q3
$6.37M Buy
67,597
+1,459
+2% +$115K 0.1% 137
2017
Q2
$5.15M Sell
66,138
-1,093
-2% -$82.1K 0.09% 136
2017
Q1
$5.38M Buy
67,231
+4
+0% +$318 0.1% 131
2016
Q4
$5.29M Sell
67,227
-638
-0.9% -$49.6K 0.11% 132
2016
Q3
$5.29M Buy
67,865
+823
+1% +$59.7K 0.12% 132
2016
Q2
$4.61M Buy
+67,042
New +$4.62M 0.11% 137

Other funds holding CMD

Congress Asset Management's CMD Position: Q4 2018 in Review

Congress Asset Management sold out of Cantel Medical Corporation (CMD) in Q4 2018, closing a stake of 65,632 shares — an estimated $6.04M sold.

Congress Asset Management first reported a position in CMD in Q2 2016 and held it in 10 quarters. The position peaked at $7.74M in Q1 2018. 253 funds tracked by Wall St. Rank hold CMD as of Q4 2018.

  • Congress Asset Management reported no remaining Cantel Medical Corporation position as of Q4 2018 after selling out during the quarter.
  • Congress Asset Management sold 65,632 Cantel Medical Corporation shares in Q4 2018, an estimated $6.04M.
  • Congress Asset Management first reported a position in Cantel Medical Corporation in Q2 2016 and held it in 10 quarters.
  • Congress Asset Management's Cantel Medical Corporation position peaked at $7.74M in Q1 2018.
  • 253 funds tracked by Wall St. Rank held Cantel Medical Corporation as of Q4 2018.

Based on Congress Asset Management's 13F filing for Q4 2018, filed 25 Jan 2019.